A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E ε4 allele-0 by Ryan J Haasl (92283)

“…<p><b>Copyright information:</b></p><p>Taken from "A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E ε4 allele"</p><p>http://www.biomedcentral.com/1471-2350/9/37</p><p>BMC Medical Genetics 2008;9():37-37.…”

A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E ε4 allele-1 by Ryan J Haasl (92283)

“…For each polymorphism, genotype frequencies are represented in the form of two pie charts, where the left chart represents genotype frequencies among individuals lacking an LQ-insert allele in exon 1 of (lhcgr1) and the right chart represents genotype frequencies among individuals possessing 1 or 2 LQ-insert alleles. …”

<b>PhoU is not substituted by SOS-induced levels of DinB (the SOS response) or by DSBs, the role of the σ^E response</b>, indicating that PhoU promotes MBR other than or... by Janet L. Gibson (736950)

Apoptosis inhibitor prevented the decrease of IIL ESP-induced TJs expression and alleviated barrier disruption of Caco-2 monolayer. by Qi Qi Lu (17721401)

“…<b>C:</b> qPCR analysis of the Z-VAD-FMK pretreatment increasing mRNA expression level of TJs in IIL ESP-treated Caco-2 monolayer. <b>D and E:</b> fluorescence microscopy of Z-VAD-FMK pretreatment recovering the expression of TJs proteins in IIL ESP-treated Caco-2 monolayer (scale bars: 20 μm) and quantitative analysis of the TJs fluorescence intensity. …”

Influence of ghrelin treatment (0.5 μg/g BW, twice a day, intraperitoneal (ip.)) on inflammatory mediators after cecal ligation and puncture (CLP)-induced sepsis. by Daniel Siegl (717509)

MCP-1-deficiency decreased CD11c-expressing cells via impairing the production of ROS and decreased activation of PLCγ2, Akt, and ERK upon M-CSF stimulation in BMM. by Woon-Ki Kim (447798)

“…<p>BMMs from WT (open bar) and MCP-1-KO mice (oblique-lined bar) were incubated in the presence of M-CSF (30 ng/ml) with U73122 (10 µM), Akt inhibitor IV (0.3 µM), PD098059 (5 µM), DPI (50 nM), NAC (3 mM), or H₂O₂ (300 µM) for 4 d (A). *, <i>P</i><0.05; ***, <i>P</i><0.001 compared with vehicle-treated WT cells. …”

An enhanced clot growth rate before in vitro fertilization decreases the probability of pregnancy by A. N. Balandina (6729380)

<i>Becn1</i>^FA/FA mutation ameliorates cerebral Aβ accumulation, memory deficits and mortality of Alzheimer’s mouse models. by Altea Rocchi (3278457)

Fig 5 - by Evelyn Medawar (9774392)

Ang 1–7 decreased tunicamycin-stimulated ER stress and improved NO bioavailability in HUVECS. by Dharmani Murugan (841819)

A decrease of <i>MHCII</i>, <i>Dl4</i>, and <i>Ccl25</i> but an increase in <i>Il7</i> in the <i>Foxn1</i>^<i>lacZ</i> thymus. by Shiyun Xiao (75798)

Average self-reported physical health ratings before or during the COVID-19 pandemic among individuals who engaged during the pandemic in more than 3 (A), 4 (B), or 5 (C) positive... by Elie Mulhem (22537863)

<i>Becn1</i>^F121A leads to autophagy hyperactivation in vivo. by Altea Rocchi (3278457)

Binding of <i>PC3/Tis21</i> to the <i>Id3</i> promoter and corresponding decrease of <i>Id3</i> mRNA. by Stefano Farioli-Vecchioli (256006)

“…<p>(<b>A–D</b>) A PC12 cell line carrying an inducible <i>PC3</i> (rat) cDNA under control of the tet-off system (i.e., a tetracycline responsive element TRE-PC3, activated by a tetracycline-regulated transactivator, CMV-tTA, in the absence of doxycycline) was used to analyze the binding of <i>PC3</i> to the <i>Id3</i> promoter, by chromatin immunoprecipitation (ChIP). …”

Phase space trajectory of <i>ϕ</i>_<i>e</i> for Δ = 2 s, and rest of the default parameters as in Table 1. by F. Deeba (8661837)

Brain uptake of [¹⁴C]docosahexaenoic acid (DHA) in 2-, 8-, 12-, and 24-month-old mice. by Takuro Iwao (14636741)

Subjects:

ATRA decreases mRNA expression of HO-1, GCLM and x-CT and lowers GSH level in BTZ-treated cells. by A. L. Furfaro (2587792)

Cellular uptake of [¹⁴C]docosahexaenoic acid (DHA) by RBECs transfected with MFSD2A siRNA. by Takuro Iwao (14636741)

Subjects:

ATRA decreases the binding of Nrf2 to ARE sequences in the promoter regions of HO-1, GCLM and x-CT in BTZ-treated cells. by A. L. Furfaro (2587792)

Tonic endocannabinoid signaling is decreased at cortical inhibitory synapses in Nlgn3^R451C mice. by Haley E. Speed (813995)